{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-004126","form_type":"8-K","ticker":null,"cik":"0001538217","company_name":"SRAX, Inc.","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.492667+00:00","generated_at":"2026-06-19T20:12:36.539615+00:00","sec_items":["1.01","1.02","2.01","3.02","3.03","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SRAX acquires ~$4M in assets from DNA Holdings, issues common & Series B preferred; Brock Pierce is interested director","bullets":["Acquired assets valued at ~$4.0M from DNA Holdings, including $1M cash, crypto assets, equity investments in 3 private companies, and customer database.","Upfront consideration: 1,313,127 common shares and 63,743 Series B Preferred shares (convertible at $1.00); 54,908 additional Series B shares placed in escrow.","Series B Preferred non-voting; initial conversion price $1.00; stated value $48.00; conversion subject to stockholder approval; 540-day lock-up on seller shares.","Amended agreements with ATW funds: reduced warrant exercise prices to $1.00, extended debenture maturity to June 2024, modified credit facility terms.","Terminated registration rights agreement with one ATW holder as part of amendment and waiver."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-004126","json":"https://secwatch.observer/filing/0001493152-23-004126.json","markdown":"https://secwatch.observer/filing/0001493152-23-004126.md","text":"https://secwatch.observer/filing/0001493152-23-004126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538217/000149315223004126/0001493152-23-004126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538217/000149315223004126/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T20:12:36.539615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"abf6cb2cef39cacea436a977c253341922ad1a50","claim":"SRAX, Inc.: Certificate of Designation for Series B Preferred Stock filed with Delaware Secretary of State on February 3, 2023, establishing powers, designations, preferences and other rights (effective 2023-02-03).","evidence_excerpt":"The Certificate of Designation establishes the powers, designations, preferences, and other rights of the Series B Preferred Stock and became effective upon filing with the Secretary of State of the State of Delaware on February 3, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538217/000149315223004126/0001493152-23-004126-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-02-03"}],"fact_type":"governance_change"},{"claim_id":"2f0c0fe797690c792bc5ef34c643345fbdceb50b","claim":"SRAX, Inc. completed an acquisition involving DNA Holdings, LLC for aggregate value of approximately $4,000,000 (closed 2023-02-03).","evidence_excerpt":"APA. Pursuant to the terms of the APA, at the closing of the Acquisition (the “Closing”), in exchange for the Purchased Assets, which have an aggregate value of approximately $4,000,000 (excluding the value of the customer database, as the Company is finalizing the valuation of such asset), the Company issued and delivered to Seller (i) 1,313,127 shares of the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538217/000149315223004126/0001493152-23-004126-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"DNA Holdings, LLC"},{"label":"Consideration","value":"aggregate value of approximately $4,000,000"},{"label":"Closing","value":"2023-02-03"}],"fact_type":"ma_transaction"},{"claim_id":"2814d0c5493819ecd0bb313f4fabe42476b2c0b3","claim":"SRAX, Inc. entered into Asset Purchase Agreement with DNA Holdings, LLC valued at approximately $4,000,000 (effective 2023-02-03).","evidence_excerpt":"On February 3, 2023 (the “Closing Date”), SRAX, Inc. (the “Company”) entered into and consummated the transactions contemplated by the Asset Purchase Agreement (the “APA”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538217/000149315223004126/0001493152-23-004126-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"DNA Holdings, LLC"},{"label":"Value","value":"approximately $4,000,000"},{"label":"Effective","value":"2023-02-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}